-
CRISPR Screening for Small Molecule Target Deconvolution
2026-05-20
Zhao et al. introduce a CRISPR/Cas9-based selection platform for unbiased identification of cellular targets of small-molecule activators of signaling pathways. This approach, demonstrated using the IFN-I pathway agonist BDW568, enables robust deconvolution of both target proteins and metabolizing enzymes, with broad implications for phenotypic drug discovery.
-
Thiazovivin (A5506): ROCK Inhibitor in Stem Cell Protocols
2026-05-20
Thiazovivin is a potent ROCK inhibitor designed to enhance the efficiency of fibroblast reprogramming and improve the survival of human embryonic stem cells after dissociation. It is best used in stem cell research workflows that require robust cell viability and reproducibility, but is not suitable for diagnostic or therapeutic applications.
-
HotStart™ 2X Green qPCR Master Mix: Technical Workflow Guide
2026-05-19
HotStart™ 2X Green qPCR Master Mix addresses the need for high-specificity, fluorescence-based DNA quantification in real-time PCR workflows by minimizing non-specific amplification and primer-dimer formation. This master mix is ideal for gene expression analysis, RNA-seq validation, and nucleic acid quantification but is not suitable for probe-based assays or applications outside SYBR Green detection.
-
Red Blood Cell Lysis Buffer: Precision in Erythrocyte Remova
2026-05-19
APExBIO's Red Blood Cell Lysis Buffer streamlines mammalian blood sample prep, maximizing nucleated cell yield for flow cytometry, nucleic acid, and protein analysis. Explore actionable protocols, advanced troubleshooting, and real-world assay enhancements grounded in recent research breakthroughs.
-
GLT-1 Upregulation Mitigates TBI via CB1-CREB Pathway Modula
2026-05-18
This study reveals that upregulating GLT-1 in astrocytes attenuates neuronal apoptosis and cognitive deficits after traumatic brain injury (TBI) by inhibiting the CB1-CREB signaling pathway. The findings provide mechanistic insight into endocannabinoid-mediated regulation of glutamate transport and suggest new therapeutic angles for TBI.
-
Hot-Melt Extrusion Enhances Ziprasidone HCl Bioavailability
2026-05-18
This study demonstrates a novel hot-melt extrusion approach using Plasdone-S630 and HPMCAS-HF to formulate ziprasidone hydrochloride solid dispersions, resulting in improved oral bioavailability and elimination of the food effect in preclinical models. These findings have significant implications for both clinical translation and the optimization of research assays involving poorly soluble antipsychotic agents.
-
Exome Sequencing Reveals Novel UV and TSA Mutation Signature
2026-05-17
This study leverages whole exome sequencing to comprehensively characterize mutation signatures induced by UVB radiation and trichostatin A (TSA) in primary human keratinocytes. The findings expand our understanding of UV-induced DNA damage, highlight new mutational hotspots relevant to skin cancer, and provide critical insight into the interplay between chromatin state and mutagenesis.
-
circHIF1A/miR-486-5p/GRHL2 Axis Drives LUAD Progression via
2026-05-16
This study reveals that circHIF1A promotes lung adenocarcinoma (LUAD) progression by modulating the tumor microenvironment through the circHIF1A/miR-486-5p/GRHL2 axis, which induces macrophage M2 polarization. The findings provide mechanistic insight into circRNA-mediated immune evasion in LUAD, highlighting new avenues for biomarker development and targeted therapies.
-
Substance P in Applied Pain Transmission Research Workflows
2026-05-15
Substance P is a gold-standard tachykinin neuropeptide for probing pain, inflammation, and immune signaling in CNS models. This guide details best practices, protocol advances, and troubleshooting strategies for maximizing data integrity with APExBIO's high-purity Substance P, integrating insights from breakthrough spectral analytics to optimize hazardous substance detection and minimize interference.
-
HotStart 2X Green qPCR Master Mix: Precision in SYBR Green q
2026-05-15
Unlock high-specificity gene expression analysis with HotStart™ 2X Green qPCR Master Mix—a gold-standard SYBR Green qPCR master mix featuring antibody-mediated hot-start Taq inhibition. This mix streamlines workflows for RNA-seq validation and nucleic acid quantification, ensuring exceptional reproducibility and minimal background.
-
BMS-345541: Optimizing IKK-1/IKK-2 Inhibition in Inflammatio
2026-05-14
BMS-345541 (free base) from APExBIO empowers researchers to precisely dissect NF-κB signaling in models of inflammation, cancer, and angiogenesis. This article distills advanced experimental workflows, troubleshooting guidance, and key innovations from recent studies, translating them into actionable protocols for robust, reproducible results.
-
Sitagliptin Phosphate Monohydrate: Rewiring Incretin Science
2026-05-14
Translational researchers face a dual challenge: deciphering the mechanistic interplay of incretin hormones and gastrointestinal (GI) stretch in metabolic disease, and translating these discoveries into robust preclinical models. This article, drawing on the latest mechanistic insights and validated experimental workflow guidance, explores how Sitagliptin phosphate monohydrate (a potent DPP-4 inhibitor from APExBIO) empowers the next generation of type II diabetes treatment research. By integrating primary literature and scenario-driven best practices, we provide actionable strategies for leveraging incretin hormone modulation in both cellular and animal models—bridging the gap between foundational biology and translational impact.
-
Paeoniflorin Modulates Tmem176b+ Macrophage Polarization in
2026-05-13
This study elucidates how paeoniflorin mitigates hepatic ischemia-reperfusion injury by driving Tmem176b+ macrophages toward a reparative phenotype. Using single-cell RNA sequencing and functional depletion assays, the authors provide direct evidence for Tmem176b+ macrophages as a therapeutic target and map downstream immunoregulatory pathways.
-
Amikacin (BAY416651): Targeted Delivery and Resistance Insig
2026-05-13
Explore how Amikacin (BAY416651) advances antibiotic resistance research through unique delivery strategies and resistance mechanisms. Uncover in-depth scientific findings not covered by conventional protocol guides.
-
Fluconazole as a Fungal Cytochrome P450 Enzyme 14α-Demethyla
2026-05-12
APExBIO’s Fluconazole is a benchmark ergosterol biosynthesis inhibitor enabling precise antifungal susceptibility profiling, drug resistance modeling, and translational Candida infection research. This guide details evidence-based protocols, advanced troubleshooting, and comparative insights for maximizing reproducibility in antifungal assays.